Arkadios Wealth Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,800
Closed -$371K 753
2023
Q2
$371K Sell
8,800
-1,500
-15% -$60.7K 0.04% 385
2023
Q1
$367K Sell
10,300
-284
-3% -$10.3K 0.04% 380
2022
Q4
$388K Buy
+10,584
New +$418K 0.05% 340
2021
Q4
Sell
-100
Closed -$8K 1881
2021
Q3
$8K Hold
100
﹤0.01% 1512
2021
Q2
$8K Hold
100
﹤0.01% 1611
2021
Q1
$7K Hold
100
﹤0.01% 1302
2020
Q4
$6K Hold
100
﹤0.01% 1099
2020
Q3
$6.08K Hold
100
﹤0.01% 822
2020
Q2
$5.92K Hold
100
﹤0.01% 762
2020
Q1
$3.94K Hold
100
﹤0.01% 834
2019
Q4
$6.59K Buy
+100
New +$5.38K ﹤0.01% 664

Other funds holding SYNH

Arkadios Wealth Advisors's SYNH Position: Q3 2023 in Review

Arkadios Wealth Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 8,800 shares — an estimated $371K sold.

Arkadios Wealth Advisors first reported a position in SYNH in Q4 2019 and held it in 11 quarters. The position peaked at $388K in Q4 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Arkadios Wealth Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 8,800 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $371K.
  • Arkadios Wealth Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2019 and held it in 11 quarters.
  • Arkadios Wealth Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $388K in Q4 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Arkadios Wealth Advisors's 13F filing for Q3 2023, filed 13 Oct 2023.